The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment-free interval (TFI) after first-line therapy (FLT) and disease control rate (DCR) on second-line therapy (SLT): Impact on overall survival (OS) in relapsed malignant pleural mesothelioma (MPM).
Maria G ViganĂ²
No relevant relationships to disclose
Vanesa Gregorc
No relevant relationships to disclose
Domenico Ghio
No relevant relationships to disclose
Alessandra Bulotta
No relevant relationships to disclose
Gilda Rossoni
No relevant relationships to disclose
Claudio Sallemi
No relevant relationships to disclose
Scialini Colombi
Employment or Leadership Position - MolMed
Gloria Rossoni
Employment or Leadership Position - MolMed
Antonio Lambiase
Employment or Leadership Position - MolMed
Claudio Bordignon
Employment or Leadership Position - MolMed